Evaluation of pituitary mass

References

Key articles

Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516-524. Abstract

Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am. 1992;21:877-901. Abstract

Vance ML. Endocrinological evaluation of acromegaly. J Neurosurg. 1998;89:499-500. Abstract

Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553-1562.Full text  Abstract

Reference articles

1. Arafah BM, Nasrallah MP. Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer. 2001 Dec;8(4):287-305.Full text  Abstract

2. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA. 2017;317:516-524. Abstract

3. Pal A, Leaver L, Wass J. Pituitary adenomas. BMJ. 2019 Jun 6;365:l2091.Full text  Abstract

4. Nishioka H, Inoshita N. New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol. 2018 Jan 9;35(2):57-61. Abstract

5. Ezzat S, Asa SL, Couldwell WT, et al. The prevalence of pituitary adenomas: a systematic review. Cancer. 2004 Aug 1;101(3):613-9.Full text  Abstract

6. Morris Z, Whiteley WN, Longstreth WT Jr, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.Full text  Abstract

7. Colao A, Loche S, Cappa M, et al. Prolactinomas in children and adolescents: clinical presentation and long-term follow-up. J Clin Endocrinol Metab. 1998;83:2777-2780.Full text  Abstract

8. Randall RV, Scheithauer BW, Laws ER Jr, et al. Pituitary adenomas associated with hyperprolactinemia: a clinical and immunohistochemical study of 97 patients operated on transsphenoidally. Mayo Clin Proc. 1985;60:753-762. Abstract

9. Jagannathan J, Dumont AS, Jane JA Jr, et al. Pediatric sellar tumors: diagnostic procedures and management. Neurosurg Focus. 2005;18:E6. Abstract

10. Nieman LK. Medical therapy of Cushing's disease. Pituitary. 2002;5:77-82. Abstract

11. Klibanski A. Nonsecreting pituitary tumors. Endocrinol Metab Clin North Am. 1987;16:793-804. Abstract

12. Yamada S, Asa SL, Kovacs K, et al. Analysis of hormone secretion by clinically nonfunctioning human pituitary adenomas using the reverse hemolytic plaque assay. J Clin Endocrinol Metab. 1989;68:73-80. Abstract

13. Socin HV, Chanson P, Delemer B, et al. The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol. 2003;148:433-442. Abstract

14. Beck-Peccoz P, Brucker-Davis F, Persani L, et al. Thyrotropin-secreting pituitary tumors. Endocr Rev. 1996;17:610-638. Abstract

15. Schubiger O, Haller D. Metastases to the pituitary-hypothalamic axis: an MR study of 7 symptomatic patients. Neuroradiology. 1992;34:131-134. Abstract

16. Heaney AP. Clinical review: Pituitary carcinoma: difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011;96:3649-3660. Abstract

17. Joshi MN, Whitelaw BC, Carroll PV. MECHANISMS IN ENDOCRINOLOGY: Hypophysitis: diagnosis and treatment. Eur J Endocrinol. 2018 Jun 7;179(3):R151-R163.Full text  Abstract

18. Faje AT, Sullivan R, Lawrence D, et al. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J Clin Endocrinol Metab. 2014 Nov;99(11):4078-85.Full text  Abstract

19. Min L, Hodi FS, Giobbie-Hurder A, et al. Systemic high-dose corticosteroid treatment does not improve the outcome of ipilimumab-related hypophysitis: a retrospective cohort study. Clin Cancer Res. 2015 Feb 15;21(4):749-55.Full text  Abstract

20. Torino F, Barnabei A, Paragliola RM, et al. Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. Eur J Endocrinol. 2013 Dec;169(6):R153-64.Full text  Abstract

21. Jadhav RN, Dahiwadkar HV, Palande DA. Abscess formation in invasive pituitary adenoma: case report. Neurosurgery. 1998;43:616-619. Abstract

22. Dalan R, Leow MK. Pituitary abscess: our experience with a case and a review of the literature. Pituitary. 2008;11:299-306. Abstract

23. Goyal P, Utz M, Gupta N, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018 Mar;8(2):219-231.Full text  Abstract

24. Abbott J, Kirkby GR. Acute visual loss and pituitary apoplexy after surgery. BMJ. 2004;329:218-219.Full text  Abstract

25. Mohr G, Hardy J. Hemorrhage, necrosis, and apoplexy in pituitary adenomas. Surg Neurol. 1982;18:181-189. Abstract

26. Levy A. Hazards of dynamic testing of pituitary function. Clin Endocrinol (Oxf). 2003;58:543-544. Abstract

27. Ucciferro P, Anastasopoulou C. Empty Sella. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019Full text  Abstract

28. Goyal P, Utz M, Gupta N, et al. Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. Quant Imaging Med Surg. 2018 Mar;8(2):219-231.Full text  Abstract

29. Fernández-Balsells MM, Murad MH, Barwise A, et al. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2011 Apr;96(4):905-12.Full text  Abstract

30. Baldeweg SE, Vanderpump M, Drake W, et al. Society for Endocrinology endocrine emergency guidance: emergency management of pituitary apoplexy in adult patients. Endocr Connect. 2016 Sep;5(5):G12-G15.Full text  Abstract

31. Freda PU, Beckers AM, Katznelson L, et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:894-904.Full text  Abstract

32. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am. 1992;21:877-901. Abstract

33. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744.Full text  Abstract

34. Fukuda I, Hizuka N, Murakami Y, et al. Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University. Intern Med. 2001;40:987-992.Full text  Abstract

35. Vance ML. Endocrinological evaluation of acromegaly. J Neurosurg. 1998;89:499-500. Abstract

36. Katznelson L, Laws ER Jr, Melmed S, et al. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014 Oct 30;99(11):3933-51.Full text  Abstract

37. Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003 Dec;88(12):5593-602.Full text  Abstract

38. Lindholm J. Cushing's syndrome: historical aspects. Pituitary. 2000;3:97-104. Abstract

39. Cappabianca P, Cirillo S, Alfieri A, et al. Pituitary macroadenoma and diaphragma sellae meningioma: differential diagnosis on MRI. Neuroradiology. 1999;41:22-26. Abstract

40. Pinzer T, Krishnan KG, Schackert G. The diaphragma sellae meningioma: a rare differential diagnosis of non-functioning pituitary adenoma. Zentralbl Neurochir. 2004;65:195-197. Abstract

41. Scott ES, Long GV, Guminski A, et al. The spectrum, incidence, kinetics and management of endocrinopathies with immune checkpoint inhibitors for metastatic melanoma. Eur J Endocrinol. 2018 Feb;178(2):173-180.Full text  Abstract

42. Ryder M, Callahan M, Postow MA, et al. Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution. Endocr Relat Cancer. 2014 Apr;21(2):371-81.Full text  Abstract

43. Famini P, Maya MM, Melmed S. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab. 2011;96:1633-1641. Abstract

44. Chin BM, Orlandi RR, Wiggins RH 3rd. Evaluation of the sellar and parasellar regions. Magn Reson Imaging Clin N Am. 2012;20:515-543. Abstract

45. American College of Radiology. ACR Appropriateness Criteria. Neuroendocrine Imaging. 2018 [internet publication].Full text

46. Shrivastava RK, Arginteanu MS, King WA, et al. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg. 2002;97:299-306. Abstract

47. Melmed S, Casanueva FF, Hoffman AR, et al; Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273-288.Full text  Abstract

48. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab. 2009;94:3647-3655. Abstract

49. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab. 2008;93:1553-1562.Full text  Abstract

50. Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract. 2009;15:335-342. Abstract

51. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008 May;93(5):1526-40.Full text  Abstract

52. Jho DH, Biller BM, Agarwalla PK, et al. Pituitary apoplexy: large surgical series with grading system. World Neurosurg. 2014;82:781-790. Abstract

Use of this content is subject to our disclaimer